表紙
市場調查報告書
商品編碼
1065619

甲狀腺消融設備市場-按類型、應用、最終用戶:全球機會分析和行業預測(2021-2030 年)

Thyroid Ablation Devices Market by Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021--2030

出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2020年全球甲狀腺消融設備市場規模達到4.7279億美元。

預計 2021 年至 2030 年間,該市場將以 10.6% 的複合年增長率增長,到 2030 年達到 129.43 萬美元。

市場的增長是由於甲狀腺結節和甲狀腺癌等甲狀腺疾病的患病率迅速上升,政府對製藥和醫療器械行業發展力度的加強,數量的增加甲狀腺消融器械產品的審批,高水平,產品開發是主要因素。

本報告調查了全球甲狀腺消融設備市場,概述了市場、按類型、應用、最終用戶、地區和進入市場的公司概況劃分的趨勢。

目錄

第1章介紹

第2章執行摘要

第3章市場情況。

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 定位為主要進入者,2020 年
  • 市場動態
    • 促進因素
      • 甲狀腺癌和甲狀腺結節的患病率增加
      • 微創手術需求增加
      • 消融設備技術進步
    • 抑制器
      • 安裝維護成本高
    • 市場機會
      • 全球醫療保健費用不斷增加
    • 影響分析
  • 分析 COVID-19 對甲狀腺消融設備市場的影響

第 4 章甲狀腺消融設備市場:按類型

  • 概覽
    • 市場規模和預測
  • 圖像引導消融
  • 高頻消融
  • 微波消融
  • 其他

第 5 章甲狀腺消融設備市場:按應用

  • 概覽
    • 市場規模和預測
  • 甲狀腺癌
  • 甲狀腺結節

第 6 章甲狀腺消融設備市場:按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院和診所
  • 門診手術中心
  • 癌症中心
  • 其他(癌症研究中心及研發公司)

第 7 章甲狀腺消融設備市場:按地區劃分

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要市場趨勢、增長動力和機遇
    • 北美甲狀腺消融設備市場:按類型
    • 北美甲狀腺消融設備市場:按應用
    • 北美甲狀腺消融設備市場:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要市場趨勢、增長動力和機遇
    • 歐洲甲狀腺消融設備市場:按類型
    • 歐洲甲狀腺消融設備市場:按應用
    • 歐洲甲狀腺消融設備市場:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他
  • 亞太地區
    • 主要市場趨勢、增長動力和機遇
    • 亞太地區甲狀腺消融設備市場:按類型
    • 亞太地區甲狀腺消融設備市場:按應用
    • 亞太地區甲狀腺消融設備市場:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他
  • 拉丁美洲、中東、非洲
    • 主要市場趨勢、增長動力和機遇
    • 拉丁美洲、中東、非洲甲狀腺消融設備市場:按類型
    • 拉丁美洲、中東、非洲甲狀腺消融設備市場:按應用
    • 拉丁美洲、中東、非洲甲狀腺消融設備市場:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
      • 拉丁美洲
      • 中東、非洲

第 8 章公司簡介

  • BOSTON SCIENTIFIC CORPORATION
  • BVM MEDICAL SYSTEM
  • INTEGRA LIFE SCIENCES
  • JOHNSON & JOHNSON(ETHICON)
  • MEDTRONIC PLC
  • MEDWAVES INC.
  • OLYMPUS CORPORATION
  • STARMED CO.LTD.
  • TERUMO CORPORATION(TERUMO EUROPE)
  • THERACLION
目錄
Product Code: LI_2113940 / A13571

The global thyroid ablation devices market was valued at $472.79 million in 2020, and is estimated to reach $1,294.43 million by 2030, growing at a CAGR of 10.6% from 2021 to 2030. Thyroid ablation is a procedure done to restore the function of thyroid gland while suffering from thyroid cancer or thyroid nodules. Thyroid is located at lower front position of the neck and it is a butterfly shaped. An active thyroid gland and too much hormone may need thyroid ablation as treatment to address medical problems such as thyroid nodules and thyroid cancer. It is a procedure done to decrease the function of thyroid gland.

Growth of the global thyroid ablation devices market is majorly driven by alarming increase in prevalence of thyroid diseases, such as thyroid nodules and thyroid cancer; rise in government initiatives for development of pharmaceutical and medical device industry; increase in number of approvals for thyroid ablation devices product; and development of advanced thyroid ablation devices product. According to the Saint John's Cancer Institute thyroid radiofrequency ablation is a non-surgical treatment option, which can reduce size of thyroid nodule. It reduces the need for nodule surgery and use of radioactive iodine. Moreover, as per the American Cancer Society Statistics 2021, in U.S, there were about 44,280 new cases of thyroid cancer, out of which 12,150 were in men and 32,130 in women. Furthermore, in June 2021, Boston Scientific acquired FARAPULSE for its electrophysiology segment which brings pulsed-field ablation technology to its portfolio. Thus, advancements in technology for advanced thyroid ablation devices products in emerging nations and urinary are expected to propel growth of the market.

Increase in government support for management of Hashimoto's thyroiditis and surge in demand for effective treatment are the major factors that drive the global thyroid ablation devices market. In addition, key players such as Sonacare Medical and Theraclion, which provide numerous ablation products for treatment of thyroid cancer contributes toward the market growth. Rise in demand for ablation devices for treatment of thyroid nodules act a key driving force for expansion of the global market.

However, high cost associated with thyroid ablation devices products for treatment of Hashimoto's disease is anticipated to hinder the market growth. People, nowadays are more aware of health, which, in turn, compels them to maintain their health condition and increase demand for thyroid ablation devices product. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the thyroid ablation devices market.

The global thyroid ablation devices market is segmented into type, application, end user, and region. By type, the market is categorized into image guided ablation, radiofrequency ablation, microwave ablation, and others.

Depending on application, it is fragmented into thyroid nodules and thyroid cancer. As per end user, it is divided into hospitals & clinics, ambulatory surgical centers, cancer specialty centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global thyroid ablation devices market are Boston Scientific Corporation, BVM Medical System, Integra Life Sciences, Johnson & Johnson, Medtronic Plc., MedWaves Inc., Olympus Corporation, StarMed Co.Ltd., Terumo Europe, and Theraclion.

.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global thyroid ablation market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region- & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Product Type

  • Image-guided Ablation
  • Radiofrequency Ablation
  • Microwave Ablation
  • Others

By Application

  • Thyroid Cancer
  • Thyroid Nodules

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Cancer Specialty Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Boston Scientific Corporation
  • BVM Medical System
  • Integra Life Sciences
  • Johnson & Johnson
  • Medtronic Plc.
  • MedWaves Inc.
  • Olympus Corporation
  • StarMed Co.Ltd.
  • Terumo Europe
  • Theraclion

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description

Key benefits for stakeholders

  • 1.2.Key market segments
  • 1.3.Research methodology
    • 1.3.1.Secondary research
    • 1.3.2.Primary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE.

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of thyroid cancer and thyroid nodules
      • 3.5.1.2.Increasing demand for minimally invasive procedures
      • 3.5.1.3.Technological advancements in ablation devices
    • 3.5.2.Restraint
      • 3.5.2.1.High cost of installation and maintenance
    • 3.5.3.Opportunity
      • 3.5.3.1.Increase in healthcare expenditure worldwide
    • 3.5.4.Impact analysis
  • 3.6.Impact analysis of COVID-19 on the thyroid ablation devices market

CHAPTER 4:THYROID ABLATION DEVICES MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Image-guided Ablation
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Radiofrequency Ablation
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Microwave Ablation
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country
  • 4.5.Others
    • 4.5.1.Key market trends, growth factors, and opportunities
    • 4.5.2.Market size and forecast, by region
    • 4.5.3.Market analysis, by country

CHAPTER 5:THYROID ABLATION DEVICES MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Thyroid Cancer
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Thyroid Nodules
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country

CHAPTER 6:THYROID ABLATION DEVICES MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Hospitals & Clinics
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Ambulatory Surgical Centers
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.Cancer Specialty Centers
    • 6.4.1.Market size and forecast, by region
    • 6.4.2.Market analysis, by country
  • 6.5.Others (Cancer research center and R & D companies)
    • 6.5.1.Market size and forecast, by region
    • 6.5.2.Market analysis, by country

CHAPTER 7:THYROID ABLATION DEVICES MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.North America thyroid ablation devices market, by type
    • 7.2.3.North America thyroid ablation devices market, by application
    • 7.2.4.North America thyroid ablation devices market, by end user
    • 7.2.5.Market size and forecast, by country
      • 7.2.5.1.U.S.
      • 7.2.5.1.1.U.S. thyroid ablation devices market, by type
      • 7.2.5.1.2.U.S. thyroid ablation devices market, by application
      • 7.2.5.1.3.U.S. thyroid ablation devices market, by end user
      • 7.2.5.2.Canada
      • 7.2.5.2.1.Canada thyroid ablation devices market, by type
      • 7.2.5.2.2.Canada thyroid ablation devices market, by application
      • 7.2.5.2.3.Canada thyroid ablation devices market, by end user
      • 7.2.5.3.Mexico
      • 7.2.5.3.1.Mexico thyroid ablation devices market, by type
      • 7.2.5.3.2.Mexico thyroid ablation devices market, by application
      • 7.2.5.3.3.Mexico thyroid ablation devices market, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Europe thyroid ablation devices market, by type
    • 7.3.3.Europe thyroid ablation devices market, by application
    • 7.3.4.Europe thyroid ablation devices market, by end user
    • 7.3.5.Market size and forecast, by country
      • 7.3.5.1.Germany
      • 7.3.5.1.1.Germany thyroid ablation devices market, by type
      • 7.3.5.1.2.Germany thyroid ablation devices market, by application
      • 7.3.5.1.3.Germany thyroid ablation devices market, by end user
      • 7.3.5.2.France
      • 7.3.5.2.1.France thyroid ablation devices market, by type
      • 7.3.5.2.2.France thyroid ablation devices market, by application
      • 7.3.5.2.3.France thyroid ablation devices market, by end user
      • 7.3.5.3.UK
      • 7.3.5.3.1.UK thyroid ablation devices market, by type
      • 7.3.5.3.2.UK thyroid ablation devices market, by application
      • 7.3.5.3.3.UK thyroid ablation devices market, by end user
      • 7.3.5.4.Italy
      • 7.3.5.4.1.Italy thyroid ablation devices market, by type
      • 7.3.5.4.2.Italy thyroid ablation devices market, by application
      • 7.3.5.4.3.Italy thyroid ablation devices market, by end user
      • 7.3.5.5.Spain
      • 7.3.5.5.1.Spain thyroid ablation devices market, by type
      • 7.3.5.5.2.Spain thyroid ablation devices market, by application
      • 7.3.5.5.3.Spain thyroid ablation devices market, by end user
      • 7.3.5.6.Rest of Europe
      • 7.3.5.6.1.Rest of Europe thyroid ablation devices market, by type
      • 7.3.5.6.2.Rest of Europe thyroid ablation devices market, by application
      • 7.3.5.6.3.Rest of Europe thyroid ablation devices market, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Asia-Pacific thyroid ablation devices market, by type
    • 7.4.3.Asia-Pacific thyroid ablation devices market, by application
    • 7.4.4.Asia-Pacific thyroid ablation devices market, by end user
    • 7.4.5.Market size and forecast, by country
      • 7.4.5.1.Japan
      • 7.4.5.1.1.Japan thyroid ablation devices market, by type
      • 7.4.5.1.2.Japan thyroid ablation devices market, by application
      • 7.4.5.1.3.Japan thyroid ablation devices market, by end user
      • 7.4.5.2.China
      • 7.4.5.2.1.China thyroid ablation devices market, by type
      • 7.4.5.2.2.China thyroid ablation devices market, by application
      • 7.4.5.2.3.China thyroid ablation devices market, by end user
      • 7.4.5.3.Australia
      • 7.4.5.3.1.Australia thyroid ablation devices market, by type
      • 7.4.5.3.2.Australia thyroid ablation devices market, by application
      • 7.4.5.3.3.Australia thyroid ablation devices market, by end user
      • 7.4.5.4.India
      • 7.4.5.4.1.India thyroid ablation devices market, by type
      • 7.4.5.4.2.India thyroid ablation devices market, by application
      • 7.4.5.4.3.India thyroid ablation devices market, by end user
      • 7.4.5.5.South Korea
      • 7.4.5.5.1.South Korea thyroid ablation devices market, by type
      • 7.4.5.5.2.South Korea thyroid ablation devices market, by application
      • 7.4.5.5.3.South Korea thyroid ablation devices market, by end user
      • 7.4.5.6.Rest of Asia-Pacific
      • 7.4.5.6.1.Rest of Asia-Pacific thyroid ablation devices market, by type
      • 7.4.5.6.2.Rest of Asia-Pacific thyroid ablation devices market, by application
      • 7.4.5.6.3.Rest of Asia-Pacific thyroid ablation devices market, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.LAMEA thyroid ablation devices market, by type
    • 7.5.3.LAMEA thyroid ablation devices market, by application
    • 7.5.4.LAMEA thyroid ablation devices market, by end user
    • 7.5.5.Market size and forecast, by country
      • 7.5.5.1.Latin America
      • 7.5.5.1.1.Latin America thyroid ablation devices market, by type
      • 7.5.5.1.2.Latin America thyroid ablation devices market, by application
      • 7.5.5.1.3.Latin America thyroid ablation devices market, by end user
      • 7.5.5.2.Middle East and Africa
      • 7.5.5.2.1.Middle East and Africa thyroid ablation devices market, by type
      • 7.5.5.2.2.Middle East and Africa thyroid ablation devices market, by application
      • 7.5.5.2.3.Middle East and Africa thyroid ablation devices market, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.BOSTON SCIENTIFIC CORPORATION
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
  • 8.2.BVM MEDICAL SYSTEM
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Key strategic moves and developments
  • 8.3.INTEGRA LIFE SCIENCES
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
  • 8.4.JOHNSON & JOHNSON (ETHICON)
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Business performance
    • 8.4.6.Key strategic moves and developments
  • 8.5.MEDTRONIC PLC
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
    • 8.5.6.Key strategic moves and developments
  • 8.6.MEDWAVES INC.
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
  • 8.7.OLYMPUS CORPORATION
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Business performance
  • 8.8.STARMED CO.LTD.
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Product portfolio
  • 8.9.TERUMO CORPORATION (TERUMO EUROPE)
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
    • 8.9.6.Key strategic moves and developments
  • 8.10.THERACLION
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio

LIST OF TABLES

  • TABLE 01.GLOBAL THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 02.THYROID ABLATION DEVICES MARKET FOR IMAGE-GUIDED ABLATION, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.THYROID ABLATION DEVICES MARKET FOR RADIOFREQUENCY ABLATION, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.THYROID ABLATION DEVICES MARKET FOR MICROWAVE ABLATION, BY REGION, 2020-2030 ($MILLION)
  • TABLE 05.THYROID ABLATION DEVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 06.GLOBAL THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 07.THYROID ABLATION DEVICES MARKET FOR THYROID CANCER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.THYROID ABLATION DEVICES MARKET FOR THYROID NODULES , BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.GLOBAL THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 10.THYROID ABLATION DEVICES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.THYROID ABLATION DEVICES MARKET FOR DRUG STORES & RETAIL PHARMACIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.THYROID ABLATION DEVICES MARKET FOR CANCER SPECIALTY CENTERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.THYROID ABLATION DEVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.GLOBAL THYROID ABLATION DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 16.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 17.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 19.U.S. THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 20.U.S. THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 21.U.S. THYROID ABLATION DEVICES MARKET, BY DISTRIBUTIO CHANNEL, 2020-2030 ($MILLION)
  • TABLE 22.CANADA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 23.CANADA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 24.CANADA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 25.MEXICO THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 26.MEXICO THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 27.MEXICO THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 28.EUROPE THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 29.EUROPE THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 30.EUROPE THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 31.EUROPE THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 32.GERMANY THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 33.GERMANY THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 34.GERMANY THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 35.FRANCE THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 36.FRANCE THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 37.FRANCE THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 38.UK THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 39.UK THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 40.UK THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 41.ITALY THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 42.ITALY THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 43.ITALY THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 44.SPAIN THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 45.SPAIN THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 46.SPAIN THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 47.REST OF EUROPE THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 48.REST OF EUROPE THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 49.REST OF EUROPE THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 50.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 51.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 52.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 54.JAPAN THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 55.JAPAN THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 56.JAPAN THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57.CHINA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 58.CHINA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 59.CHINA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 60.AUSTRALIA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 61.AUSTRALIA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 62.AUSTRALIA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 63.INDIA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 64.INDIA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 65.SOUTH KOREA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 66.INDIA THYROID ABLATION DEVICES MARKET, END USER, 2020-2030 ($MILLION)
  • TABLE 67.REST OF ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 68.REST OF ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 69.REST OF ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 70.LAMEA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 71.LAMEA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 72.LAMEA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 73.LAMEA THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 74.LATIN AMERICA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 75.LATIN AMERICA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 76.LATIN AMERICA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.MIDDLE EAST AND AFRICA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 78.MIDDLE EAST AND AFRICA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 79.MIDDLE EAST AND AFRICA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 80.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 81.BOSTON SCIENTIFIC : OPERATING SEGMENTS
  • TABLE 82.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 83.BVM: COMPANY SNAPSHOT
  • TABLE 84.BVM: OPERATING SEGMENTS
  • TABLE 85.BVM: PRODUCT PORTFOLIO
  • TABLE 86.BVM: KEY DEVELOPMENTS
  • TABLE 87.INTEGRA: COMPANY SNAPSHOT
  • TABLE 88.INTEGRA: PRODUCT SEGMENTS
  • TABLE 89.INTEGRA: PRODUCT PORTFOLIO
  • TABLE 90.J & J: COMPANY SNAPSHOT
  • TABLE 91.J & J: OPERATING BUSINESS SEGMENT
  • TABLE 92.J & J: PRODUCT PORTFOLIO
  • TABLE 93.J & J: KEY DEVELOPMENTS
  • TABLE 94.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 95.MEDTRONIC: PRODUCT SEGMENTS
  • TABLE 96.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 97.MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 98.MEDWAVES: COMPANY SNAPSHOT
  • TABLE 99.MEDWAVES: PRODUCT PORTFOLIO
  • TABLE 100.OLYMPUS: COMPANY SNAPSHOT
  • TABLE 101.OLYMPUS: PRODUCT SEGMENTS
  • TABLE 102.OLYMPUS: PRODUCT PORTFOLIO
  • TABLE 103.STARMED: COMPANY SNAPSHOT
  • TABLE 104.STARMED: PRODUCT PORTFOLIO
  • TABLE 105.TERUMO: COMPANY SNAPSHOT
  • TABLE 106.TERUMO: OPERATING BUSINESS SEGMENTS
  • TABLE 107.TERUMO: PRODUCT PORTFOLIO
  • TABLE 108.TERUMO: KEY DEVELOPMENTS
  • TABLE 109.THERACLION: COMPANY SNAPSHOT
  • TABLE 110.THERACLION: OPERATING SEGMENTS
  • TABLE 111.THERACLION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.THYROID ABLATION DEVICES MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2020-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2020-2021
  • FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.HIGH THREAT OF SUBSTITUTES
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.HIGH INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR IMAGE-GUIDED ABLATION, BY COUNTRY, 2020-2030 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR RADIOFREQUENCY ABLATION, BY COUNTRY, 2020-2030 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR BARBITURATE, BY COUNTRY, 2020-2030 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR THYROID CANCER, BY COUNTRY, 2020-2030 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR STROKE, BY COUNTRY, 2020-2030 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTER, BY COUNTRY, 2020-2030 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR CANCER SPECIALTY CENTERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 23.BOSTON SCIENTIFIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 24.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 25.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 26.INTEGRA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 27.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 28.INTEGRA: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 29.J & J: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 30.J & J: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 31.J & J: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 32.MEDTRONIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 33.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 34.MEDTRONIC: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 35.OLYMPUS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 36.OLYMPUS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 37.OLYMPUS: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 38.TERUMO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 39.TERUMO: REVENUE SHARE BY SEGMENT, 2020 (%)